Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes

ClinicalTrials.gov ID: NCT00106366

Public ClinicalTrials.gov record NCT00106366. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety Comparison of Insulin Detemir and Insulin Glargine Plus Insulin Aspart in Patients With Type 2 Diabetes

Study identification

NCT ID
NCT00106366
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
389 participants

Conditions and interventions

Interventions

  • insulin aspart Drug
  • insulin detemir Drug
  • insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2005
Primary completion
Nov 30, 2005
Completion
Nov 30, 2005
Last update posted
Jan 30, 2017

2005

United States locations

U.S. sites
68
U.S. states
26
U.S. cities
63
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35235
Novo Nordisk Investigational Site Vestavia Hills Alabama 35209
Novo Nordisk Investigational Site Little Rock Arkansas 72204
Novo Nordisk Investigational Site Searcy Arkansas 72143
Novo Nordisk Investigational Site Chula Vista California 91911
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Inglewood California 90301
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site Orange California 92868
Novo Nordisk Investigational Site Santa Ana California 92705
Novo Nordisk Investigational Site Santa Barbara California 93105
Novo Nordisk Investigational Site Santa Monica California 90404
Novo Nordisk Investigational Site Aurora Colorado 80045
Novo Nordisk Investigational Site Longmont Colorado 80501
Novo Nordisk Investigational Site Newark Delaware 19702
Novo Nordisk Investigational Site Aventura Florida 33180
Novo Nordisk Investigational Site Delray Beach Florida 33484
Novo Nordisk Investigational Site Lake Mary Florida 32746
Novo Nordisk Investigational Site Longwood Florida 32779
Novo Nordisk Investigational Site Ocala Florida 34471
Novo Nordisk Investigational Site Orlando Florida 32804
Novo Nordisk Investigational Site Plantation Florida 33324
Novo Nordisk Investigational Site West Palm Beach Florida 33407
Novo Nordisk Investigational Site Atlanta Georgia 30032
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Powder Springs Georgia 30127
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Springfield Illinois 62711
Novo Nordisk Investigational Site Des Moines Iowa 50314
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Baltimore Maryland 21204
Novo Nordisk Investigational Site Saint Paul Minnesota 55108
Novo Nordisk Investigational Site Kansas City Missouri 64114
Novo Nordisk Investigational Site St Louis Missouri 63141
Novo Nordisk Investigational Site Las Vegas Nevada 89102
Novo Nordisk Investigational Site Reno Nevada 89502-0111
Novo Nordisk Investigational Site Berlin New Jersey 08009
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site West Seneca New York 14224
Novo Nordisk Investigational Site Asheville North Carolina 28801
Novo Nordisk Investigational Site Greensboro North Carolina 27408
Novo Nordisk Investigational Site Monroe North Carolina 28204
Novo Nordisk Investigational Site Raleigh North Carolina 27609
Novo Nordisk Investigational Site Canton Ohio 44718
Novo Nordisk Investigational Site Franklin Ohio 45005
Novo Nordisk Investigational Site Kettering Ohio 45429
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Clinton Oklahoma 73601
Novo Nordisk Investigational Site Tulsa Oklahoma 74104
Novo Nordisk Investigational Site Medford Oregon 97504
Novo Nordisk Investigational Site Duncan South Carolina 29334
Novo Nordisk Investigational Site Chattanooga Tennessee 37404
Novo Nordisk Investigational Site Arlington Texas 76014
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390-8858
Novo Nordisk Investigational Site Houston Texas 77030
Novo Nordisk Investigational Site Midland Texas 79707
Novo Nordisk Investigational Site Plano Texas 75093
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Newport News Virginia 23606
Novo Nordisk Investigational Site Richmond Virginia 23249
Novo Nordisk Investigational Site Richmond Virginia 23294
Novo Nordisk Investigational Site Olympia Washington 98502
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00106366, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00106366 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →